4//SEC Filing
Talmo Paul 4
Accession 0001062993-25-003496
CIK 0001561921other
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 4:57 PM ET
Size
10.1 KB
Accession
0001062993-25-003496
Insider Transaction Report
Form 4
TELA Bio, Inc.TELA
Talmo Paul
Chief Technology Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-02-21+56,100→ 56,100 totalExercise: $2.72Exp: 2035-02-21→ Common Stock (56,100 underlying) - Tax Payment
Common Stock
2025-02-23$2.72/sh−4,061$11,046→ 125,121 total - Award
Common Stock
2025-02-21+38,100→ 129,182 total - Tax Payment
Common Stock
2025-02-24$2.65/sh−1,049$2,780→ 124,072 total
Footnotes (3)
- [F1]These restricted stock units ("RSUs") will vest in four equal annual installments beginning on February 21, 2026, subject to the Reporting Person's continuous service through the applicable vesting dates.
- [F2]Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs.
- [F3]The option vests 25% on February 21, 2026, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates.
Issuer
TELA Bio, Inc.
CIK 0001561921
Entity typeother
Related Parties
1- filerCIK 0001899089
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 4:57 PM ET
- Size
- 10.1 KB